Vertex Pharmaceuticals VRTX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.03B-13.4% | $1.19B+10.0% | $1.08B+4.8% | $1.03B+59.8% | $646.3M— | ||
| $55.9M+0.4% | $55.7M+3.1% | $54M+4.4% | $51.7M+6.8% | $48.4M+4.1% | ||
| $166.4M+5.6% | $157.6M-19.1% | $194.9M+16.5% | $167.3M+0.7% | $166.1M-1.0% | ||
| $1.43B+187% | $498M-59.9% | $1.24B+15.7% | $1.07B+31.0% | $818.9M+765% | ||
| $133.4M-10.7% | $149.4M+46.8% | $101.8M-30.1% | $145.7M+258% | $40.7M-56.0% | ||
| -$431.9M-49.9% | -$288.1M-146% | -$117M+75.9% | -$484.5M-768% | -$55.8M+93.2% | ||
| $336.9M+162% | $128.4M-88.0% | $1.07B+173% | $391.8M-8.0% | $426.1M+2.0% | ||
| -$538.8M-598% | -$77.2M+93.3% | -$1.15B-231% | -$349.2M+48.7% | -$680.4M-73.9% | ||
| $417.1M+198% | $140M— | $0-100% | $296.6M+162% | $113.2M+117% | ||
| $1.29B+271% | $348.6M-69.4% | $1.14B+22.9% | $927.4M+19.2% | $778.2M+494% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Vertex Pharmaceuticals generate?
- Vertex Pharmaceuticals (VRTX) generated $4.2B in operating cash flow over the trailing twelve months.
- What is Vertex Pharmaceuticals's free cash flow?
- After $530.3M of capital expenditures, Vertex Pharmaceuticals's free cash flow was $3.7B over the trailing twelve months, up 207.9% year over year.
- Where does Vertex Pharmaceuticals's cash flow data come from?
- Every line is extracted from Vertex Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
